The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

About Us
Understanding AML


Updated April 17, 2024

The term ‘prognosis’ describes the predicted outcome of a medical condition, including how it may respond to treatment in a particular patient. For example, if a patient has a condition with no known treatments, they may be described as having a poor prognosis.

In acute myeloid leukemia, prognosis differs from person to person, and there are a number of factors that can influence how a patient progresses, including:

  • age and overall health;
  • the type of acute myeloid leukemia you have, particularly the genetic/chromosomal abnormalities present;
  • whether acute myeloid leukemia has spread to the brain and spinal cord;
  • the total number of white blood cells in the blood;
  • treatment for previous cancers;
  • a history of blood disorders;
  • infection at the time of acute myeloid leukemia diagnosis; and
  • response to chemotherapy and prior relapse.

Your leukemia specialist may discuss your prognosis with you after taking one or more of these factors into account.

Do you feel more informed about what factors affect prognosis in acute myeloid leukemia?

In this section

What is acute myeloid leukemia?Causes & symptomsDiagnosisTypesTreatmentPrognosisRemissionRelapseCOVID-19Caregivers

Latest story

Hear from Dorcas about her experience of caring for someone with acute myeloid leukemia.

Asset 1

Sign up to the newsletter


Share this page